Efanesoctocog alfa (Altuviiio)
Jump to navigation
Jump to search
Mechanism of action
From Wikipedia: Efanesoctocog alfa is a recombinant DNA-derived, Factor VIII concentrate.
Diseases for which it is used
History of changes in FDA indication
- 2023-02-22: Initial approval for use in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: (1) Routine prophylaxis to reduce the frequency of bleeding episodes; (2) On-demand treatment and control of bleeding episodes; and (3) Perioperative management of bleeding. (Based on XTEND-1)
- 2024-05-10: Approval updated to include additional evidence. (Based on XTEND-Kids)
Also known as
- Code name: BIVV-001
- Brand name: Altuviiio